Clinical Trial Update: A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for HB0028 in advanced solid tumors and cervical cancer across Phase 1/Phase 2; no results data provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Solid Tumor

Drugs mentioned

• HB0028

Snippet

Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd. | Conditions: Advanced Solid Tumor, Cervical Cancer | Phase 1, Phase 2 | Status: UNKNOWN